Blood pressure pills may stop prehypertension from becoming Full-Blown disease
NCT ID NCT07652567
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at whether giving low-dose blood pressure medication to people with high-normal blood pressure and other risk factors could prevent them from developing full-blown hypertension, diabetes, or heart problems. 690 participants aged 50-79 were given either telmisartan, indapamide, or a placebo. The goal was to see if these drugs could reduce the risk of new-onset hypertension, diabetes, and cardiovascular events like stroke or heart attack.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Telmisartan and Indapamide
- What this could lead to
- If successful, this could show that low-dose blood pressure medication helps prevent the onset of hypertension and related heart issues in at-risk individuals.
- What could go wrong
- This is a completed study, but results may not apply to everyone. The drugs have side effects, and the benefit may be small for some people.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIGH-NORMAL BLOOD PRESSURE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Qilu Hospital of Shandong University
Jinan, Shandong, 250000, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.